The identity problem.
D000818:Animals; D000925:Anticoagulants / Q000737:chemistry / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000331:legislation & jurisprudence; D016568:Drugs, Generic / Q000627:therapeutic use*; D017984:Enoxaparin / Q000737:chemistry / Q000627:therapeutic use; D000068717:Glatiramer Acetate; D006801:Humans; D010455:Peptides / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000925:Anticoagulants; D016568:Drugs, Generic; D017984:Enoxaparin; D010455:Peptides; D000068717:Glatiramer Acetate